0001225208-14-017103.txt : 20140716
0001225208-14-017103.hdr.sgml : 20140716
20140716161121
ACCESSION NUMBER: 0001225208-14-017103
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140715
FILED AS OF DATE: 20140716
DATE AS OF CHANGE: 20140716
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Phalen Michael P.
CENTRAL INDEX KEY: 0001483882
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 14978204
MAIL ADDRESS:
STREET 1: C/O BOSTON SCIENTIFIC
STREET 2: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
4
1
doc4.xml
X0306
4
2014-07-15
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001483882
Phalen Michael P.
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
EVP & President, MedSurg
Common Stock
2014-07-15
4
M
0
45000.0000
7.4100
A
172486.0000
D
Common Stock
2014-07-15
4
M
0
22500.0000
8.3000
A
194986.0000
D
Common Stock
2014-07-15
4
S
0
67500.0000
13.0370
D
127486.0000
D
Common Stock
2433.0000
I
By 401(k)
Stock Option (Right to Buy)
7.4100
2014-07-15
4
M
0
45000.0000
0.0000
D
2020-02-16
Common Stock
45000.0000
8692.0000
D
Stock Option (Right to Buy)
8.3000
2014-07-15
4
M
0
22500.0000
0.0000
D
2019-02-24
Common Stock
22500.0000
2779.0000
D
The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $12.98 to $13.08, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 16, 2011, the first anniversary of the date of grant.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2010, the first anniversary of the date of grant.
/s/ Lee G. Giguere, Attorney-in-Fact
2014-07-16